Boost For SUN PHARMA | U.S.FDA Nod for 1st Product From Halol | CNBC TV18

326 views · Published 18 July 2018 · 2:20 · Indexed 8 November 2026

Channel: CNBC-TV18 · 2018 · News & Politics

Watch on YouTube

Sun Pharma, India’s largest drug maker, on Wednesday said it got its first-ever USFDA approval for a product filed from the Halol facility in Gujarat after receipt of Establishment Inspection Report (EIR) last month.

EIR indicates closure of US FDA inspection.

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Website: https://www.cnbctv18.com/

More from this channel